RALA Peptide

CAT: 0952-B2019179Size: 1 mgDry Ice: NoHazardous: No
CAT#:0952-B2019179Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
RALA Peptide_x000D_ Catalog number: B2019179_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mg_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Powder_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: RALA Peptide_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: McCrudden CM, Bennie L, Chambers P, Wilson J, Kerr M, Ziminska M, Douglas H, Kuhn S, Carroll E, O'Brien G, Buckley N, Dunne NJ, McCarthy HO. Peptide delivery of a multivalent mRNA SARS-CoV-2 vaccine J Control Release. 2023 Oct;362:536-547._x000D_ 2: Bennett R, Yakkundi A, McKeen HD, McClements L, McKeogh TJ, McCrudden CM, Arthur K, Robson T, McCarthy HO. RALA-mediated delivery of FKBPL nucleic acid therapeutics Nanomedicine (Lond). 2015 Oct;10(19):2989-3001._x000D_ 3: Bombin ADJ, Dunne N, McCarthy HO. Delivery of a peptide/microRNA blend via electrospun antimicrobial nanofibres for wound repair Acta Biomater. 2023 Jan 1;155:304-322._x000D_ 4: O'Doherty M, Mulholland EJ, Chambers P, Pentlavalli S, Ziminska M, Chalanqui MJ, Pauly HM, Sathy BN, Donahue TH, Kelly DJ, Dunne N, McCarthy HO. Improving the Intercellular Uptake and Osteogenic Potency of Calcium Phosphate via Nanocomplexation with the RALA Peptide Nanomaterials (Basel). 2020 Dec 7;10(12):2442._x000D_ 5: McErlean EM, McCrudden CM, McBride JW, Cole G, Kett VL, Robson T, Dunne NJ, McCarthy HO. Rational design and characterisation of an amphipathic cell penetrating peptide for non-viral gene delivery Int J Pharm. 2021 Mar 1;596:120223._x000D_ 6: Chambers P, Ziminska M, Elkashif A, Wilson J, Redmond J, Tzagiollari A, Ferreira C, Balouch A, Bogle J, Donahue SW, Dunne NJ, McCarthy HO. The osteogenic and angiogenic potential of microRNA-26a delivered via a non-viral delivery peptide for bone repair J Control Release. 2023 Oct;362:489-501._x000D_ 7: Graham JP, Castro JG, Werba LC, Fardone LC, Francis KP, Ramamurthi A, Layden M, McCarthy HO, Gonzalez-Fernandez T. Versatile Cell Penetrating Peptide for Multimodal CRISPR Gene Editing in Primary Stem Cells bioRxiv [Preprint]. 2024 Sep 23:2024.09.23.614499._x000D_ 8: Jain AK, Massey A, Yusuf H, McDonald DM, McCarthy HO, Kett VL. Development of polymeric-cationic peptide composite nanoparticles, a nanoparticle-in-nanoparticle system for controlled gene delivery Int J Nanomedicine. 2015 Nov 24;10:7183-96._x000D_ 9: McCrudden CM, McBride JW, McCaffrey J, McErlean EM, Dunne NJ, Kett VL, Coulter JA, Robson T, McCarthy HO. Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer Cancer Nanotechnol. 2018;9(1):5._x000D_ 10: Liu Y, Wan HH, Tian DM, Xu XJ, Bi CL, Zhan XY, Huang BH, Xu YS, Yan LP. Development and Characterization of High Efficacy Cell-Penetrating Peptide via Modulation of the Histidine and Arginine Ratio for Gene Therapy Materials (Basel). 2021 Aug 19;14(16):4674. _x000D_ _x000D_ Products Related to RALA Peptide can be found at Proteins
Short Description
Catalog Number: B2019179 (1 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5

Related Products

CatalogName
B2024481Rabbit Polyclonal Phospho-RalA (Ser194) Antibody (Human)
B2018995TKD Peptide (Hsp70 Peptide)
B2014551SAMS Peptide
B2019237G2 Peptide
B2019223Peptide Cp40
MDP0572Peptide T
B2019189VPM Peptide
MDP0634MCD-Peptide
B2019186Oyster Peptide
B2014731CGRGDS Peptide

Alternative Products

CatalogName
MBS3847510-01RALA peptide
A22930-10RALA peptide 10mg
MBS9627178-01RALA Blocking Peptide
A22930-1RALA peptide 1mg
A22930-5RALA peptide 5mg
MBS3237842-01RALA Peptide - middle region
MBS3237841-01Rala Peptide - N-terminal region
AAP56643-100UGRALA Peptide - middle region (AAP56643)
AAP56642-100UGRala Peptide - N-terminal region (AAP56642)
MBS9223925-01RALA Antibody (C-term) Blocking Peptide

Popular Products